Amgen Inc Stock Widgets and Gadgets
AMGN Stock | USD 305.71 1.15 0.37% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- AMGN Amgen Inc
- Latest Verastem Oncology Announces Multiple Presentations Focused on RASMAPK Pathway Inhibition at AACR Annual Meeting 2025
- AMGN 305.71 -1.15
- Low 304.35
- High 309.09
- Volume 2.4 M
- Alpha 0.27
- Beta 0.46
- Return On Equity 0.68
- Return On Asset 0.064
- Profit Margin 0.12 %
- Operating Margin 0.52 %
- Current Valuation 212.97 B
- Shares Outstanding 537.2 M
- Shares Owned By Insiders 0.21 %
- Shares Owned By Institutions 82.08 %
- Number Of Shares Shorted 16.08 M
- Price To Earning 22.74 X
- Price To Book 28.05 X
- Price To Sales 4.93 X
- Revenue 33.42 B
- Gross Profit 22.97 B
- EBITDA 13.36 B
- Net Income 4.09 B
- Cash And Equivalents 11.48 B
- Cash Per Share 21.51 X
- Total Debt 60.1 B
- Current Ratio 1.68 X
- Book Value Per Share 10.95 X
- Cash Flow From Operations 11.49 B
- Short Ratio 4.87 X
- Earnings Per Share 7.55 X
- Price To Earnings To Growth 1.04 X
- Target Price 315.95
- Number Of Employees 28 K
- Beta 0.52
- Market Capitalization 164.85 B
- Total Asset 91.84 B
- Retained Earnings (27.59 B)
- Working Capital 5.93 B
- Current Asset 38.52 B
- Current Liabilities 8.67 B
- Annual Yield 0.03 %
- Five Year Return 2.82 %
- Net Asset 91.84 B
- Last Dividend Paid 9.0
- Accumulation Distribution 36425.08
- Daily Balance Of Power (0.24)
- Rate Of Daily Change 1.0
- Day Median Price 306.72
- Day Typical Price 306.38
- Price Action Indicator (1.59)
- Period Momentum Indicator (1.15)
- Relative Strength Index 57.75
Market Snapshot Widget Example
DAX Index Germany | 22,839 1.17 | |
Taiwan Weighted Taiwan | 22,260 0.06 | |
PSI 20 Stock Portugal | 6,887 0.80 | |
CROBEX Croatia | 3,342 0.09 | |
Budapest SE Hungary | 92,222 0.64 | |
IDX 30 Jakarta Indonesia | 385.25 5.16 | |
ISEQ 20 Price Ireland | 1,800 0.93 | |
NYSE Comp USA | 19,586 0.47 | |
Tel Aviv 35 Israel | 2,440 1.23 | |
Coreshares Index Tracker South Afric | 1,125 0.09 | |
IPC MEXICO Mexico | 52,807 0.75 | |
KL Technology Malaysia | 50.54 0.30 | |
IBEX 35 Index Spain | 13,432 0.39 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 4,279 0.19 | |
SPASX Dividend Opportunities Australia | 1,646 0.98 | |
HNX 30 Vietnam | 502.01 1.15 | |
Bucharest BET-NG Romania | 1,262 0.07 | |
AMS Small Cap Netherlands | 1,404 0.15 | |
Oslo Exchange Mutual Norway | 1,491 0.39 | |
BEL Small Belgium | 8,532 1.81 | |
Basic Materials Brazil | 5,496 0.69 | |
Swiss Leader Price Switzerland | 2,096 0.66 | |
Fondo Mutuo ETF Chile | 1,564 0.08 | |
Athens General Comp Greece | 1,747 1.17 | |
Stock Exchange Of Thailand | 1,190 0.46 | |
PX Prague Stock Czech Repub | 2,116 0.15 | |
THE PHILIPPINE STOCK Philippines | 6,166 0.10 | |
WIG 30 Poland | 3,529 1.1 | |
BIST Electricity Turkey | 456.17 0.14 |
Investing Ideas
In addition to having Amgen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Amgen
Compare Amgen To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.19) | Dividend Share 9 | Earnings Share 7.55 | Revenue Per Share | Quarterly Revenue Growth 0.109 |
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.